hypertension
Reading File
Asking for Preferences
Finding Sources
Searching PubMed
hypertension management guidelines
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Loading Image
Reading File
Reading File
Loading Image
This covers all aspects you requested. Here's a quick orientation to the sections above:
- Section 1–2: ACC/AHA classification table, white-coat vs. masked HTN, epidemiology
- Section 3: Pathophysiology of primary HTN (RAAS, SNS, sodium, obesity, arterial stiffness)
- Section 4: Diagnostic workup — which labs to order and why, plus BP measurement pearls
- Section 5: CVD risk quantification
- Section 6: Full treatment algorithm with both flowcharts, nonpharmacologic BP reduction table, and four first-line drug classes with combination strategies
- Section 7: Target organ damage across heart, brain, kidneys, eyes, vessels
- Section 8: Six causes of secondary HTN with screening tests; flagged the new 2025 primary aldosteronism guideline
- Section 9: Emergency vs. urgency distinction, IV drugs with specific indications, condition-specific BP targets
- Section 10: The October 2025 AHA/ACC guideline (most current U.S. guidance)
Let me know if you want to go deeper on any specific area — drug pharmacology, pediatric HTN, pregnancy-related HTN, renal denervation, or anything else.
This is a shared conversation. Sign in to Orris to start your own chat.